顺铂水针剂与粉针剂联合化疗方案治疗肺癌的随机临床研究

目的 比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性。方法 小细胞肺癌(SCLC)67例。给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗。患者被随机纳入顺铂水剂组和粉剂组,两组间同类型肺癌所用药物种类、剂量一致。结果 SCLC水剂组与粉剂组的有效率分别为84.8%与82.4%(P>0.05),NSCLC分别为31.6%与29.9%(P>0.05)。水剂组与粉剂组毒性反应主要为胃肠道反应和骨髓抑制,其中急性恶心呕吐发生率分别为72.3%与65.8%(P<0.05),迟发性恶心呕吐分别为60.7%与53.2%(P<0.05);两组间血液毒性及肾毒性无显著性差...

Full description

Saved in:
Bibliographic Details
Published inZhongguo fei ai za zhi Vol. 7; no. 3; pp. 243 - 246
Main Author 任莉 鄢希 勾红峰 邱萌 李潞 朱江
Format Journal Article
LanguageChinese
Published 610041,成都,四川大学华西医院肿瘤中心化疗科 2004
Subjects
Online AccessGet full text
ISSN1009-3419
1999-6187

Cover

Abstract 目的 比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性。方法 小细胞肺癌(SCLC)67例。给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗。患者被随机纳入顺铂水剂组和粉剂组,两组间同类型肺癌所用药物种类、剂量一致。结果 SCLC水剂组与粉剂组的有效率分别为84.8%与82.4%(P>0.05),NSCLC分别为31.6%与29.9%(P>0.05)。水剂组与粉剂组毒性反应主要为胃肠道反应和骨髓抑制,其中急性恶心呕吐发生率分别为72.3%与65.8%(P<0.05),迟发性恶心呕吐分别为60.7%与53.2%(P<0.05);两组间血液毒性及肾毒性无显著性差异。SCLC水剂组与粉剂组平均住院费用分别为12468.73元与9278.66元(P<0.05),NSCLC分别为17253.64元与14881.72元(P<0.05)。结论 顺铂水针剂虽使用方便,但疗效较粉针剂无明显提高,且胃肠反应更重,治疗费用更高,临床上应酌情选用。
AbstractList 目的 比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性。方法 小细胞肺癌(SCLC)67例。给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗。患者被随机纳入顺铂水剂组和粉剂组,两组间同类型肺癌所用药物种类、剂量一致。结果 SCLC水剂组与粉剂组的有效率分别为84.8%与82.4%(P>0.05),NSCLC分别为31.6%与29.9%(P>0.05)。水剂组与粉剂组毒性反应主要为胃肠道反应和骨髓抑制,其中急性恶心呕吐发生率分别为72.3%与65.8%(P<0.05),迟发性恶心呕吐分别为60.7%与53.2%(P<0.05);两组间血液毒性及肾毒性无显著性差异。SCLC水剂组与粉剂组平均住院费用分别为12468.73元与9278.66元(P<0.05),NSCLC分别为17253.64元与14881.72元(P<0.05)。结论 顺铂水针剂虽使用方便,但疗效较粉针剂无明显提高,且胃肠反应更重,治疗费用更高,临床上应酌情选用。
R734.2%R730.53; 目的比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性.方法小细胞肺癌(SCLC)67例,给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗.患者被随机纳入顺铂水剂组和粉剂组,两组间同类型肺癌所用药物种类、剂量一致.结果SCLC水剂组与粉剂组的有效率分别为84.8%与82.4%(P>0.05),NSCLC分别为31.6%与29.9%(P>0.05).水剂组与粉剂组毒性反应主要为胃肠道反应和骨髓抑制,其中急性恶心呕吐发生率分别为72.3%与65.8%(P<0.05),迟发性恶心呕吐分别为60.7%与53.2%(P<0.05);两组间血液毒性及肾毒性无显著性差异.SCLC水剂组与粉剂组平均住院费用分别为12 468.73元与9 278.66元(P<0.05),NSCLC分别为17 253.64元与14881.72元(P<0.05).结论顺铂水针剂虽使用方便,但疗效较粉针剂无明显提高,且胃肠反应更重,治疗费用更高,临床上应酌情选用.
Author 任莉 鄢希 勾红峰 邱萌 李潞 朱江
AuthorAffiliation 四川大学华西医院肿瘤中心化疗科,成都610041
AuthorAffiliation_xml – name: 610041,成都,四川大学华西医院肿瘤中心化疗科
Author_xml – sequence: 1
  fullname: 任莉 鄢希 勾红峰 邱萌 李潞 朱江
BookMark eNotjj9Lw0Achg-pYFv9EE5Ogd8ll0tulOI_KLp0L3dpEltLggYRshkcUikqWiIWBzu6SSlS49dpkuZbeBCn9xke3vdtoJrne_YGqmPGmEKxadQkAzBFI5htoUYQDACoyjRSR6flLC1fovxrUT7H2ShaLR-K-aji9e0ke4qzcVIkr3nyk8_ifP4reR2lxdu4mN6V08f8PV0tF1l6X3xMis_vbbTp8GFg7_xnE3UODzqtY6V9dnTS2m8rlm7qiikEZ9zBFDR5D0zb0IEZGGyH9wQlAjNMBbcoF4YtCKVqT-fY1AATrhucqloT7VW1N9xzuOd2B_71lScHu6Hr8DBUAQhIX5fmbmVa577nXvalK5svnP7Q7jIGGAPR_gAryHLl
ClassificationCodes R734.2%R730.53
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL A randomized clinical trial of cisplatin solution and cisplatin powder combination regimens in the treatment of patients with lung cancer
EISSN 1999-6187
EndPage 246
ExternalDocumentID zgfazz200403015
9901104
GroupedDBID ---
-05
04C
29R
2B.
2C~
2RA
2WC
3V.
5GY
5VS
6PF
92F
92I
92L
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CDYEO
CIEJG
CQIGP
CW9
CXBCV
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
CCPQU
PGMZT
PHGZM
PHGZT
PMFND
PSX
ID FETCH-LOGICAL-c585-8bba9af160361808e7509710efadb64b1916bac6ab7eb4662d5a183014a57a623
ISSN 1009-3419
IngestDate Thu May 29 03:56:16 EDT 2025
Thu Nov 24 20:31:56 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords 顺铂/治疗应用
非小细胞肺癌/药物疗法
小细胞肺癌/药物疗法
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c585-8bba9af160361808e7509710efadb64b1916bac6ab7eb4662d5a183014a57a623
Notes R730.53
R734.2
12-1395/R
PageCount 4
ParticipantIDs wanfang_journals_zgfazz200403015
chongqing_backfile_9901104
PublicationCentury 2000
PublicationDate 2004
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationTitle Zhongguo fei ai za zhi
PublicationTitleAlternate Chinese Journal of Lung Cancer
PublicationTitle_FL CHINESE JOURNAL OF LUNG CANCER
PublicationYear 2004
Publisher 610041,成都,四川大学华西医院肿瘤中心化疗科
Publisher_xml – name: 610041,成都,四川大学华西医院肿瘤中心化疗科
SSID ssj0062934
ssib002262905
ssib001103766
ssib038074678
ssib044765436
ssib051369142
Score 1.6433363
Snippet 目的 比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性。方法 小细胞肺癌(SCLC)67例。给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗。患者被随机纳入顺铂水剂组和粉剂...
R734.2%R730.53; 目的比较顺铂水针剂与粉针剂治疗肺癌的疗效和毒性.方法小细胞肺癌(SCLC)67例,给予EP方案,非小细胞肺癌(NSCLC)156例,给予NP方案化疗.患者被随机纳入顺铂水...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 243
SubjectTerms 小细胞肺癌/药物疗法
非小细胞肺癌/药物疗法
顺铂/治疗应用
Title 顺铂水针剂与粉针剂联合化疗方案治疗肺癌的随机临床研究
URI http://lib.cqvip.com/qk/91098A/20043/9901104.html
https://d.wanfangdata.com.cn/periodical/zgfazz200403015
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib044765436
  issn: 1009-3419
  databaseCode: M~E
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BENPR
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest East & South Asia Database
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BVBZV
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastsouthasia
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1daxNBcKkVxBfxE1s_6IP7eHJ72ezH421yoQgtIhX6Vu6zBSGl2r7kzeJDK0WllorFB_vom5QiNf6dJmn-hTN7l-RaAn5AOCazM7OzM7mb2cvuLCGPdCVlFZFxx2Mxd3joZo72EumkPIbw7IVJZs8GnJsXs8_5k8Xq4sSl3dKqpY316HHcGruv5H-8CjjwK-6S_QfPDoUCAmDwL1zBw3D9Kx_TQFOfUeMjoCtUeTQQ1LjUcIvxqFI0qFKlbROnRlEV0EBS4yFyDA0QMKo5YrQ7aKpRLZALrlpiFwAYjQD0jjQCBRpTolEoDRUDjEYJCPhU5YoB0LByapbGKmZsp_BVWS7ftWoAoKkR5Ry6oPfrVklDTX1cdyC8bkcEMhtUD8Ot5TZWWWsMpUctGvXzcx5orI1awAjAk5vOH5BUwNTnmEEFhmLRcrVz71NGb1IFFs-D8GFVVJYWWSs4DETaIcEHO5A4BgB80EpaoE59YbWpW0eCFezwcifhmDSO3_cGFmlYiyiUULYa4KHHMa6V2FF-sFkRqvBvLazGV45lsnTLVspxKa-FVaQ4Hr9QfdzmM63lLGy10CQ4Tca6DZC8ykly2QTzT5-NcmzcWVqe83vC06OggQcYQPAdPtQ5l7h9eUhfhUeDZnxY4w2Y86Ufg-FgkZOV1ebyGqRudiddMwuby6Wkb-E6uVbM1mb8_Na7QSZaKzfJlbliPcotMt8_bPc_bna_H_d3tzrbm6cn73pH2zl89nqv82Grs7Pf2__U3f_ZPdzqHv0C-Gyz3fu80zt40z943_3SPj057rTf9r7u9b79uE0WGsFCbdYpTihxYphmOyqKQh1meFK7YMpVKabfkLKnWZhEgkcM5l5RGIswkmnEhfCSaggh1GU8rMoQJh53yGRztZneJTM6YTzNMi4lyzgDOiCMIzBNEiuXZ8kUmR5aBRLc-AWWbVvCP7WZy6fITGGmpeLp9Grpgjen_0xyj1zNl6Xh-8X7ZHL95Ub6ADLu9ehh8Rv4DdLFptw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%A1%BA%E9%93%82%E6%B0%B4%E9%92%88%E5%89%82%E4%B8%8E%E7%B2%89%E9%92%88%E5%89%82%E8%81%94%E5%90%88%E5%8C%96%E7%96%97%E6%96%B9%E6%A1%88%E6%B2%BB%E7%96%97%E8%82%BA%E7%99%8C%E7%9A%84%E9%9A%8F%E6%9C%BA%E4%B8%B4%E5%BA%8A%E7%A0%94%E7%A9%B6&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E4%BB%BB%E8%8E%89&rft.au=%E9%84%A2%E5%B8%8C&rft.au=%E5%8B%BE%E7%BA%A2%E5%B3%B0&rft.au=%E9%82%B1%E8%90%8C&rft.date=2004&rft.pub=610041%2C%E6%88%90%E9%83%BD%2C%E5%9B%9B%E5%B7%9D%E5%A4%A7%E5%AD%A6%E5%8D%8E%E8%A5%BF%E5%8C%BB%E9%99%A2%E8%82%BF%E7%98%A4%E4%B8%AD%E5%BF%83%E5%8C%96%E7%96%97%E7%A7%91&rft.issn=1009-3419&rft.volume=7&rft.issue=3&rft.spage=243&rft.epage=246&rft.externalDocID=zgfazz200403015
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg